/
/
Informar de un problemaAnálisis en profundidad sobre las actividades del fondo
Co-inversores
| Nombre | Nivel | Co-inversiones | Socios principales | Área de enfoque | Etapa preferida | Países inversores | Promedio rondas |
|---|---|---|---|---|---|---|---|
 Goldman Sachs | 2 | 2 | 0 | ||||
 J.P. Morgan | 2 | 2 | 0 | #Privacy+2 | Series C | #United States | $ 20-50M |
 Accenture | 3 | 2 | 0 | #Layer 1 (L1)+2 | Series C | #United States | $ 20-50M |
 ASX Limited | 4 | 2 | 0 | #Layer 1 (L1)+2 | Series C | #United States | $ 20-50M |
 Deutsche Borse | 4 | 2 | 0 | #Layer 1 (L1)+2 | Series C | #United States | $ 20-50M |
 Citi Ventures | 4 | 2 | 0 | #Layer 1 (L1)+2 | Series C | #United States | $ 20-50M |
 DTCC | 4 | 2 | 0 | #Layer 1 (L1)+2 | Series C | #United States | $ 20-50M |
 Polychain Capital | 1 | 1 | 0 | #Healthcare+1 | Post-ipo | #United States | |
 ARK Invest | 3 | 1 | 0 | #Healthcare+1 | Post-ipo | #United States | |
 Tradeweb | 3 | 1 | 0 | #Treasury Manageme...+1 | Post-ipo | #United States | |
 BNP Paribas | 4 | 1 | 0 | #Smart Contract Pl...+2 | #United States | ||
 PNC | 4 | 1 | 0 | #Smart Contract Pl...+2 | #United States | ||
 NEX Group | 4 | 1 | 0 | #Privacy+2 | #United States | ||
 IBM | 4 | 1 | 0 | #Layer 1 (L1)+2 | Series C | #United States | $ 20-50M |
 7RIDGE | 4 | 1 | 0 | #Healthcare+1 | Post-ipo | #United States | |
 Liberty City Ventures | 4 | 1 | 0 | #Treasury Manageme...+1 | Post-ipo | #United States | |
 Nima Capital | 4 | 1 | 0 | #Healthcare+1 | Post-ipo | #United States | |
 DRW Venture Capital | 4 | 1 | 0 | #Healthcare+1 | Post-ipo | #United States | |
 Kraken | 1 | 0 | #Treasury Manageme...+1 | Post-ipo | #United States | ||
 Canton Foundation | 1 | 0 | #Healthcare+1 | Post-ipo | #United States |
1 - 20 de 20
Mostrar filas
20